Efficacy of chemotherapy or chemo‐anti‐PD‐1 combination after failed anti‐PD‐1 therapy for relapsed and refractory hodgkin lymphoma: A series from lysa centers von Rossi, Cédric, Gilhodes, Julia, Maerevoet, Marie, Herbaux, Charles, Morschhauser, Franck, Brice, Pauline, Garciaz, Sylvain, Borel, Cécile, Ysebaert, Loïc, Obéric, Lucie, Lazarovici, Julien, Deau, Bénédicte, Dupuis, Jehan, Chauchet, Adrien, Abraham, Julie, Bijou, Fontanet, Stamatoullas‐Bastard, Aspasia, Malfuson, Jean‐Valère, Golfier, Camille, Laurent, Camille, Pericart, Sarah, Traverse‐Glehen, Alexandra, Kanoun, Salim, Filleron, Thomas, Casasnovas, René‐Olivier, Ghesquières, Hervé

Volltext

Characteristics of cells with engraftment capacity within CD34+ cell population upon G-CSF and Plerixafor mobilization von Mombled, Margaux, Rodriguez, Laura, Avalon, Maryse, Duchez, Pascale, Vlaski-Lafarge, Marija, Debeissat, Christelle, Pérard, Baptiste, Sawai, Katherine M., Pasquet, Jean Max, Bijou, Fontanet, Thévenot, Florian, Cabantous, Txomin, Ivanovic, Zoran, Brunet de la Grange, Philippe

Volltext

Does early disease progression predict survival after first line‐treatment of Waldenström macroglobulinemia? von Labreuche, Julien, Assouan, Deborah, Durot, Eric, Tomowiak, Cecile, Roos‐Weil, Damien, Toussaint, Elise, Bijou, Fontanet, Lemal, Richard, Brion, Annie, Laribi, Kamel, Ysebaert, Loic, Duhamel, Alain, Morel, Pierre

Volltext

Prognostic role of CD4 T-cell depletion after frontline fludarabine, cyclophosphamide and rituximab in chronic lymphocytic leukaemia von Gauthier, Martin, Durrieu, Françoise, Martin, Elodie, Peres, Michael, Vergez, François, Filleron, Thomas, Obéric, Lucie, Bijou, Fontanet, Quillet Mary, Anne, Ysebaert, Loic

Volltext

A single center evaluation of cost savings related to treatment‐free remission in chronic myeloid leukemia patients: the prerequisites of a pharmaco‐economy larger study von Etienne, Gabriel, Dulucq, Stéphanie, Faberes, Carole, Bijou, Fontanet, Schmitt, Anna, Klein, Emilie, Fort, Marie‐Pierre, Durrieu, Françoise, Toulza, Emilie, Mahon, François‐Xavier

Volltext

Deciphering Genetic Alterations of Hairy Cell Leukemia and Hairy Cell Leukemia-like Disorders in 98 Patients von Maitre, Elsa, Tomowiak, Cécile, Lebecque, Benjamin, Bijou, Fontanet, Benabed, Khaled, Naguib, Dina, Kerneves, Pauline, Cornet, Edouard, Viailly, Pierre-Julien, Arsham, Jeffrey, Sola, Brigitte, Jardin, Fabrice, Troussard, Xavier

Volltext

Obinutuzumab plus Lenalidomide (GALEN) for the treatment of relapse/refractory aggressive lymphoma: a phase II LYSA study von Houot, Roch, Cartron, Guillaume, Bijou, Fontanet, de Guibert, Sophie, Salles, Gilles A., Fruchart, Christophe, Bouabdallah, Krimo, Maerevoet, Marie, Feugier, Pierre, Le Gouill, Steven, Tilly, Hervé, Casasnovas, Rene-Olivier, Moluçon-Chabrot, Cécile, Van Den Neste, Eric, Zachee, Pierre, Andre, Marc, Bonnet, Christophe, Haioun, Corinne, Van Hoof, Achiel, Van Eygen, Koen, Molina, Lysiane, Nicolas-Virelizier, Emmanuelle, Ruminy, Philippe, Morschhauser, Franck

Volltext

A French multicentric prospective prognostic cohort with epidemiological, clinical, biological and treatment information to improve knowledge on lymphoma patients: study protocol o... von Ghesquieres, Herve, Rossi, Cedric, Cherblanc, Fanny, Le Guyader-Peyrou, Sandra, Bijou, Fontanet, Sujobert, Pierre, Fabbro-Peray, Pascale, Bernier, Adeline, Belot, Aurelien, Chartier, Loic, Fornecker, Luc-Matthieu, Baldi, Isabelle, Bouabdallah, Krimo, Laurent, Camille, Oberic, Lucie, Morineau, Nadine, Le Gouill, Steven, Morschhauser, Franck, Haioun, Corinne, Damaj, Gandhi, Guidez, Stephanie, Laboure, Gaelle, Fitoussi, Olivier, Lebras, Laure, Gressin, Remy, Salles, Gilles, Ysebaert, Loic, Monnereau, Alain

Volltext

Incidences of Deep Molecular Responses and Treatment-Free Remission in de Novo CP-CML Patients von Etienne, Gabriel, Dulucq, Stephanie, Bauduer, Frederic, Adiko, Didier, Lifermann, Francois, Dagada, Corinne, Lenoir, Caroline, Schmitt, Anna, Klein, Emilie, Madene, Samia, Fort, Marie-Pierre, Bijou, Fontanet, Moldovan, Marius, Turcq, Beatrice, Robbesyn, Fanny, Durrieu, Francoise, Versmee, Laura, Katsahian, Sandrine, Faberes, Carole, Lascaux, Axelle, Mahon, Francois-Xavier

Volltext

Role of Calcium Signaling in GA101-Induced Cell Death in Malignant Human B Cells von Latour, Simon, Zanese, Marion, Le Morvan, Valérie, Vacher, Anne-Marie, Menard, Nelly, Bijou, Fontanet, Durrieu, Francoise, Soubeyran, Pierre, Savina, Ariel, Vacher, Pierre, Bresson-Bepoldin, Laurence

Volltext

Cerebellum/liver index on baseline 18F-FDG PET/CT to improve prognostication in post-transplant lymphoproliferative disorders: a multicenter retrospective study von Morland, David, Kanagaratnam, Lukshe, Hubelé, Fabrice, Toussaint, Elise, Choquet, Sylvain, Kas, Aurélie, Caquot, Pierre-Ambroise, Haioun, Corinne, Itti, Emmanuel, Leprêtre, Stéphane, Decazes, Pierre, Bijou, Fontanet, Schwartz, Paul, Jacquet, Caroline, Chauchet, Adrien, Matuszak, Julien, Kamar, Nassim, Payoux, Pierre, Durot, Eric

Volltext

Incidence and outcome of BCR‐ABL mutated chronic myeloid leukemia patients who failed to tyrosine kinase inhibitors von Etienne, Gabriel, Dulucq, Stéphanie, Huguet, Françoise, Schmitt, Anna, Lascaux, Axelle, Hayette, Sandrine, Fort, Marie‐Pierre, Sujobert, Pierre, Bijou, Fontanet, Morisset, Stéphane, Tavitian, Suzanne, Bidet, Audrey, Turcq, Beatrice, Robbesyn, Fanny, Chollet, Claudine, Belloc, Francis, Durrieu, Françoise, Mahon, François‐Xavier, Nicolini, Franck E.

Volltext

Baseline 18F‐FDG Metabolic Tumor Volume Predicts Response to Rituximab Induction in Post‐transplant Lymphoproliferative Disorders: A Multi‐institutional Retrospective Study von Morland, David, Kanagaratnam, Lukshe, Hubelé, Fabrice, Toussaint, Elise, Choquet, Sylvain, Kas, Aurélie, Caquot, Pierre‐Ambroise, Haioun, Corinne, Itti, Emmanuel, Leprêtre, Stéphane, Decazes, Pierre, Bijou, Fontanet, Schwartz, Paul, Jacquet, Caroline, Chauchet, Adrien, Matuszak, Julien, Kamar, Nassim, Payoux, Pierre, Durot, Eric

Volltext

Phase Ib study of avadomide (CC‐122) in combination with rituximab in patients with relapsed/refractory diffuse large B‐cell lymphoma and follicular lymphoma von Nastoupil, Loretta J., Kuruvilla, John, Chavez, Julio C., Bijou, Fontanet, Witzig, Thomas E., Santoro, Armando, Flinn, Ian W., Boccomini, Carola, Kenkre, Vaishalee P., Corradini, Paolo, Isufi, Iris, Andorsky, David J., Klein, Leonard M., Greenwald, Daniel R., Sangha, Randeep, Shen, Frank, Hagner, Patrick, Li, Yan, Dobmeyer, Juergen, Gong, Nian, Uttamsingh, Shailaja, Pourdehnad, Michael, Ribrag, Vincent

Volltext

Relevance of treatment‐free remission recommendations in chronic phase chronic leukemia patients treated with frontline tyrosine kinase inhibitors von Etienne, Gabriel, Faberes, Carole, Bauduer, Fréderic, Adiko, Didier, Lifermann, François, Dagada, Corinne, Lenoir, Caroline, Schmitt, Anna, Klein, Emilie, Fort, Marie‐Pierre, Bijou, Fontanet, Turcq, Beatrice, Robbesyn, Fanny, Durrieu, Françoise, Versmée, Laura, Madene, Samia, Moldovan, Marius, Katsahian, Sandrine, Charles‐Nelson, Anais, Lascaux, Axelle, Mahon, François‐Xavier, Dulucq, Stéphanie

Volltext

STAT1 activation in association with JAK2 exon 12 mutations von Godfrey, Anna L, Chen, Edwin, Massie, Charles E, Silber, Yvonne, Pagano, Francesca, Bellosillo, Beatriz, Guglielmelli, Paola, Harrison, Claire N, Reilly, John T, Stegelmann, Frank, Bijou, Fontanet, Lippert, Eric, Boiron, Jean-Michel, Döhner, Konstanze, Vannucchi, Alessandro M, Besses, Carlos, Green, Anthony R

Volltext

Early-onset invasive aspergillosis and other fungal infections in patients treated with ibrutinib von Ghez, David, Calleja, Anne, Protin, Caroline, Baron, Marine, Ledoux, Marie-Pierre, Damaj, Gandhi, Dupont, Mathieu, Dreyfus, Brigitte, Ferrant, Emmanuelle, Herbaux, Charles, Laribi, Kamel, Le Calloch, Ronan, Malphettes, Marion, Paul, Franciane, Souchet, Laetitia, Truchan-Graczyk, Malgorzata, Delavigne, Karen, Dartigeas, Caroline, Ysebaert, Loïc, on behalf on the French Innovative Leukemia Organization (FILO) CLL group

Volltext

P1080: ZANUBRUTINIB PLUS OBINUTUZUMAB VERSUS OBINUTUZUMAB IN PATIENTS WITH RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA: UPDATED ANALYSIS OF THE ROSEWOOD STUDY von Trotman, Judith, Luigi Zinzani, Pier, Mayer, Jiri, Flowers, Chris, Bijou, Fontanet, Carla Oliveira, Ana, Bouabdallah, Kamal, Johnson, Rod, Martin Garcia-Sancho, Alejandro, Provencio Pulla, Mariano, Trneny, Marek, Tilly, Hervé, Jurczak, Wojciech, Ivanova, Elena, Kim, Pil, Greenbaum, Adam, Huang, Sha, Delarue, Richard, Auer, Rebecca

Volltext

The MAGNOLIA Trial: Zanubrutinib, a Next-Generation Bruton Tyrosine Kinase Inhibitor, Demonstrates Safety and Efficacy in Relapsed/Refractory Marginal Zone Lymphoma von Opat, Stephen, Tedeschi, Alessandra, Linton, Kim, McKay, Pamela, Hu, Bei, Chan, Henry, Jin, Jie, Sobieraj-Teague, Magdalena, Zinzani, Pier Luigi, Coleman, Morton, Thieblemont, Catherine, Browett, Peter, Ke, Xiaoyan, Sun, Mingyuan, Marcus, Robert, Portell, Craig A., Ardeshna, Kirit, Bijou, Fontanet, Walker, Patricia, Hawkes, Eliza A., Mapp, Sally, Ho, Shir-Jing, Talaulikar, Dipti, Zhou, Ke-Shu, Co, Melannie, Li, Xiaotong, Zhou, Wenxiao, Cappellini, Massimo, Tankersley, Chris, Huang, Jane, Trotman, Judith

Volltext

Efficacy of Chemo-Free Combination Therapy with BRAF Inhibitor and Rituximab in Classic Hairy Cell Leukemia: Insights from the French Experience von Inchiappa, Luca, Willems, Lise, Paillassa, Jérôme, Herbaux, Charles, Tomowiak, Cecile, Lok, Anne, Lara, Diane, Fontanet, Bijou, Tauveron-Jalenques, Urbain, Ittel, Antoine, Caillet, Adrien, Vey, Norbert, Troussard, Xavier

Volltext